Research Article of Research Journal of Pharmacology and Pharmacy
Osteosarcoma’s STAT-3 Vrs Kaempferia parviflora’s Compounds : Possible Drug Candidates
Chandra Sekhar Tripathy1, Anil Kumar2, Santosh Kumar Panda3, Santosh Kumar Behera4, Gaurav Giri5, Asadollah Asadi6, Santanu Kumar Budhia7, Arash Abdolmaleki8, Easter Khura9, P K Mohanta10, Muhammad Akram11, Deepak Bhattacharya12*
1M.Sc., Regional Medical Research Centre, Bhubaneswar, Odisha, India; 2Principal Scientist & Head, Division of Design of Experiments I.C.A.R-I.A.S.R.I., Library Avenue, New Delhi, India, PIN- 110012; 3 MS, ENT Surgeon, Capital Hospital; Govt., Bhubaneswar, Odisa, India; 4Ph.D., Scientist Grade II, National Institute of Pharmaceutical Education and Research, Ahmedabad, Gujarat,India; 5BAMS, Govt Drug Inspector, AYUSH, Govt of Odisha, Bhubaneswar, India; 6Associate Professor, Department of Biology, University of Mohaghegh Ardabili, Iran; 7BA; Traditional Ayurvedacharya, Nagharen Temple Rd, Baabajee Padaa, Balangir, Odisha,India PIN – 767025; 8Assistant Professor, Animal Physiology, University of Mohaghegh Ardabili, Faculty of Advanced Technologies. Department of Biology; 9M Sc (nursing), Vice Principal, School of Nursing, Raxaul, Bihar, India – 845305; 10MD (Ay), Govt Drug Inspector; Registrar Ay Council; Principal. IGMMC & Hospital, H-2/58,SS Enclave,Khandagiri,Bhubaneswar-751030, Odisha; 11BEMS, M.Phil, Ph.D, Chairperson, Dept. of Eastern Medicine, Government Collage University, Faisalabad, Pakistan; 12Ph.D., Policy, Nursing, At Fight-Cancer at Home, Medicinal Toxicology & QC, At : Sri Radha Krishna Raas Mandir, KedarGouri Road, Bhubaneswar–751002, Odisa, India.
Osteosarcoma is a dominant type of bone cancer, associated with osteophytes (bone cells). Afflicts all age groups; generally manifesting in long bones of human physiology(also other parts; including fine joints). Chemotherapy, surgery and radiation are the current therapeutics – with uncertain results; often associated with high degree of failure; swift relapse; rebound aggression and above all with debilitating post treatment out come conditions. In this investigation in silico drug designing procedures have been used to predict natural compounds from Kaempferia parviflora (black ginger) as possible drug candidates for osteosarcoma. 8 of its phyto-compounds (PCs) are found to be non-toxic and also pass the Lipinski’s rule of 5 (@ 100%) vis-à-vis the over expressed Signal Transducer And Activator Of Transcription 3(STAT3) protein of the dreaded osteosarcoma. All the 8 PCs indicate better binding affinity (greater likeness) than the current best popular allopathic drug Zoledronic acid (Toxic). All the 8 offer good-excellent likeness. Alpha- Copaene (non Toxic) emerges as the Champion.
Keywords: Phytochemicals, STAT3, bone cancer, Sarcoma, In silico, molecular docking.
How to cite this article:
Chandra Sekhar Tripathy, Anil Kumar, Santosh Kumar Panda, Santosh Kumar Behera, Gaurav Giri, Asadollah Asadi, Santanu Kumar Budhia, Arash Abdolmaleki, Easter Khura, P K Mohanta, Muhammad Akram, Deepak Bhattacharya.Osteosarcoma’s STAT-3 Vrs Kaempferia parviflora’s Compounds :Possible Drug Candidates.Research Journal of Pharmacology and Pharmacy, 2022, 6:15. DOI: 10.28933/rjpp-2022-01-1805
REFERENCES
1. DeVita, V. T., Lawrence, T. S., & Rosenberg, S. A. (Eds.). (2008). DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology (Vol. 2). Lippincott Williams & Wilkins.
2. Etymological Dictionary, 1650s, “fleshy excrescence,” Medical Latin, from Greek sarkoma “fleshy substance” (Galen), from sarkoun “to produce flesh, grow fleshy,” from sarx (genitive sarkos) “flesh” (see sarcasm) + -oma. Meaning “harmful tumor of the connective tissue” first recorded 1804
3. Siegel Rebecca, L., & Miller Kimberly, D. (2019). Jemal Ahmedin. Cancer statistics, 2019. CA: a cancer journal for clinicians, 69(1), 7-34.
4. Moore, D. D., &Luu, H. H. (2014). Osteosarcoma. Orthopaedic oncology, 65-92.
5. Gurney, J. G., Severson, R. K., Davis, S., & Robison, L. L. (1995). Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type. Cancer, 75(8), 2186-2195.
6. Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K.,… & Winkler, K. (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. Journal of clinical oncology, 20(3), 776-790.
7. Machak, G. N., Tkachev, S. I., Solovyev, Y. N., Sinyukov, P. A., Ivanov, S. M., Kochergina, N. V.,… &Glebovskaya, V. V. (2003, February). Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. In Mayo Clinic Proceedings (Vol. 78, No. 2, pp. 147-155). Elsevier.
8. Williams, S. A., Steyn, M., Meyer, M. R., Smilg, J. S., Churchill, S. E., Odes, E. J.,… & Berger, L. R. (2016). Osteogenic tumour in Australopithecus sediba: Earliest hominin evidence for neoplastic disease.
9. Khandelwal, R., Chauhan, A. P., Bilawat, S., Gandhe, A., Hussain, T., Hood, E. A.,… & Singh, S. K. (2018). Structure-based virtual screening for the identification of high-affinity small molecule towards STAT3 for the clinical treatment of Osteosarcoma. Current topics in medicinal chemistry, 18(29), 2511-2526.
10. Techaprasan, J., Klinbunga, S., Ngamriabsakul, C., &Jenjittikul, T. (2010). Genetic variation of Kaempferia (Zingiberaceae) in Thailand based on chloroplast DNA (psbA-trnH and petA-psbJ) sequences. Genetics and Molecular Research, 9(4), 1957-1973.
11. Saokaew, S., Wilairat, P., Raktanyakan, P., Dilokthornsakul, P., Dhippayom, T., Kongkaew, C.,… & Chaiyakunapruk, N. (2017). Clinical effects of Krachaidum (Kaempferia parviflora): a systematic review. Journal of evidence-based complementary & alternative medicine, 22(3), 413-428.
12. Bairoch, A., Apweiler, R., Wu, C. H., Barker, W. C., Boeckmann, B., Ferro, S.,… & Yeh, L. S. L. (2005). The universal protein resource (UniProt). Nucleic acids research, 33(suppl_1), D154-D159.
13. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H.,… &Bourne, P. E. (2000). Th e protein data bank. Nucleic Acids Res, 28(1), 235-242.
14. Kalathiya, U., Padariya, M., Faktor, J., Coyaud, E., Alfaro, J. A., Fahraeus, R.,… & Goodlett, D. R. (2021). Interfaces with structure dynamics of the workhorses from cells revealed through cross-linking mass spectrometry (CLMS). Biomolecules, 11(3), 382.
15. Binkowski, T. A., Naghibzadeh, S., & Liang, J. (2003). CASTp: computed atlas of surface topography of proteins. Nucleic acids research, 31(13), 3352-3355.
16. Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A.,… & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic acids research, 44(D1), D1202-D1213.
17. Lipinski, C. A. (2004). Lead-and drug-like compounds: the rule-of-five revolution. Drug discovery today: Technologies, 1(4), 337-341.
18. Yao, Z. J., Dong, J., Che, Y. J., Zhu, M. F., Wen, M., Wang, N. N.,…& Cao, D. S. (2016). TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models. Journal of computer-aided molecular design, 30(5), 413-424.
19. Banerjee, P., Eckert, A. O., Schrey, A. K., &Preissner, R. (2018). ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic acids research, 46(W1), W257-W263.
20. Kiss, R., Sandor, M., &Szalai, F. A. (2012). http://Mcule. com: a public web service for drug discovery. Journal of cheminformatics, 4(1), 1-1.
21. LOKESH, R., &Kannabiran, K. (2016). A HANDBOOK ON PROTEIN LIGAND DOCKING TOOL: AUTODOCK4
22. Conry, R. M., Rodriguez, M. G., & Pressey, J. G. (2016). Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients. Clinical sarcoma research, 6(1), 1-7.
23. Pitakpawasutthi, Y., Palanuvej, C., & Ruangrungsi, N. (2018). Quality evaluation of Kaempferia parviflora rhizome with reference to 5, 7-dimethoxyflavone. Journal of advanced pharmaceutical technology & research, 9(1), 26.
24. Song, K., Saini, R. K., Keum, Y. S., &Sivanesan, I. (2021). Analysis of Lipophilic Antioxidants in the Leaves of Kaempferia parviflora Wall. Ex Baker Using LC–MRM–MS and GC–FID/MS. Antioxidants, 10(10), 1573.
25. Park, H. Y., Kim, K. S., Ak, G., Zengin, G., Cziáky, Z., Jekő, J.,… &Sivanesan, I. (2021). Establishment of a Rapid Micropropagation System for Kaempferia parviflora Wall. Ex Baker: Phytochemical Analysis of Leaf Extracts and Evaluation of Biological Activities. Plants, 10(4), 698.
26. M. Dell’Agli, et.al., 2009. Journal of Ethnopharmacology, Vol. 125, No. 2, 2009, pp. 279-285. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.1091.6637&rep=rep1&type=pdf
27. M. Dell’Agli, et.al., 2009. Malaria Journal, Vol. 9, No. 1. https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-9-208
28. Bhattacharya Deepak, 2017. Fight Malaria at Home: Ghare Maro Malaria Social Service to Drug Discovery – Bottom Up Model: A Review, Air Water Borne Diseases, 2017, Vol.6:1 DOI: 10.4172/2167-7719.1000135
29. Bhattacharya Deepak, 2017. Nursing Defeats Cancer, Jor of Nursing & Health Care, Vol.5(3), (juniper); https://juniperpublishers.com/jojnhc/archive.php
30. Bhattacharya Deepak, et.al., 2021. COVID Stage 5 Vrs Punica Granatum–Best Recorded of Cure Case Series; API: Ellagic Acid & Ellagitanins. Pakistan Journal of Medical and Health Sciences, Vol.15 (5), pp. 1124-1126. DOI: https://doi.org/10.53350/pjmhs211551124
31. Bhattacharya Deepak, et al., 2021. Covid Nursing: Less Known Aspects. Saudi J Nurs Health Care, Vol. 4(10): 317-332. https://saudijournals.com/media/articles/SJNHC_410_317-332_810dT0H.pdf
32. Bhattacharya Deepak, et.al., 2020. COVID–19 and Indian Medicine Sources Drug Discovery Attempt, Indian Journal Of Natural Sciences, Vol.10 / Issue 61. https://www.researchgate.net/publication/343979504_COVID_-2019_and_Indian_Medicine_Sources_Drug_Discovery_Attempt
33. Bhattacharya Deepak, et.al, 2020. Punica Granatum Vrs Covid-19 Fruit to Drug. Research Journal of Pharmacology and Pharmacy, Huston, USA,Vol. 4:9. https://escipub.com/Articles/RJPP/RJPP-2020-08-0305.pdf
34. Behera, S. K., et.al., 2021. Drug Repurposing For Identification Of Potential Inhibitors Against Sars-Cov-2 Spike Receptor-Binding Domain: An In Silico Approach. The Indian Journal Of Medical Research, 153(1-2), pp.132. https://www.ncbi.nlm.nih.gov/pmc/issues/383375/
35. Bhattacharya Deepak, et.al., 2013. Transmission Blocking of Resistant Malaria with OMARIA, British Jor of Pharmaceutical Research; 3(1): 54-77. https://www.hilarispublisher.com/open-access/indian-monsoon-climate-and-malaria-medical-meteorology-2470-6965-1000141.pdf
36. Bhattacharya D., 2006, Atmospheric Low Pressure & Human Health: Medical Meteorology, Vayu Mandal, India Meteorological Society, New Delhi, Vol.32 (3&4), July- Dec 2006, pp.58-61. DOI: 10.5376/ijccr.2013.03.0002. https://www.researchgate.net/publication/236144484_Medical_Meteorology_India_Select_Aspects
37. Bhattacharya D. & B.K.Misra, Medical Meteorology India: Select Aspects, International Journal of Clinical Case Reports, 2013, Vol.3, No.2, pp.7-16. doi: 10.5376/ijccr.2013.03.0002. Doi: 10.4172/2470-6965.1000141
38. Lee, M. H., Han, et.al., (2018). Antiskin Inflammatory Activity Of Black Ginger (Kaempferia parviflora) Through Antioxidative Activity. Oxidative Medicine And Cellular Longevity. https://www.hindawi.com/journals/omcl/2018/5967150/
39. Bhattacharya Deepak, 2017. Nano Tech Tablet: A Concept, Novel Approaches In Drug Designing & Approaches, Vo.2 (2). https://www.researchgate.net/publication/318345705_Nano_Tech_Tablet_A_Concept
40. Bhattacharya Deepak, A Novel Anti-Metastasis and Chemotherapy’s Side Effect Reducer, Translational Medicine, (Sunnyvale), 2016, 6:3. http://dx.doi.org/10.4172/2161-1025.1000178
41. Chandra Sekhar Tripathy, et.al., 2022. Psoriasis Vrs Cassia Fistula: In-Silico Study. Saudi J Med, 7(3): 148-158. DOI: 10.36348/sjm.2022. v07i03.005
Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site/services, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).
CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.